Search Results

• • 3,169 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Combination therapy, taken once daily, may control asthma

  Author:Robert FinnFrom:Family Practice News (Vol. 34, Issue 15)

  Aug. 1, 2004414 words Article SAN FRANCISCO -- A single daily dose of fluticasone propionate / salmeterol was safe and effective in asthma control, Dr. Paul Dorinsky reported in a poster session at the annual meeting of the American Academy of...

• Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand

  Authors:E.R. Honrado, W. Fungladda, P. Kamoiratanaku, D. Kitayaporn, J. Karbwang, K. Thimasarn, et al.From:Bulletin of the World Health Organization (Vol. 77, Issue 3) Peer-Reviewed

  Mar. 19995,851 words Article A randomized, controlled, malaria-clinic-based field trial was carried out to compare the cost-effectiveness of a 5-day 700-mg oral artesunate and a 7-day quinine + tetracycline regimen for the treatment of...

• Loseasonique

  From:MPR Obstetrician & Gynecologist Edition (Vol. 20, Issue 3) Peer-Reviewed

  Fall 2009159 words Brief article, Drug ... Company: Duramed Rx Pharmacologic class: Combination extended-cycle oral contraceptive (progestin + estrogen) Active ingredients: Levonorgestrel 0.1mg + ethinyl estradiol 20micrograms (84 orange tabs); ethinyl...

• Tenofovir induced Fanconi syndrome: A possible pharmacokinetic interaction

  Authors:Jigar Kapadia, Samidh Shah, Chetna Desai, Mira Desai, Shivani Patel, Asha Shah, et al.From:Indian Journal of Pharmacology (Vol. 45, Issue 2) Peer-Reviewed

  March-April 20131,383 words Clinical report 1430LByline: Jigar. Kapadia, Samidh. Shah, Chetna. Desai, Mira. Desai, Shivani. Patel, Asha. Shah, R. Dikshit Tenofovir was introduced as a second line drug for the treatment of human immunodeficiency virus (HIV)...

• Progress toward elimination of malaria in Nigeria: Uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City

  Authors:Obehi Akoria and Isibor ArhuideseFrom:Annals of African Medicine (Vol. 13, Issue 3) Peer-Reviewed

  July-September 20144,846 words Report 1720LByline: Obehi. Akoria, Isibor. Arhuidese Background: The Roll Back Malaria (RBM) Partnership converged in Abuja in 2000. In 2005, Nigeria adopted artemisinin-based combination therapies (ACTs) as first-line therapy...

• Adjuvant chemotherapy with six cycles of AC regimen versus three cycles of AC regimen followed by three cycles of Paclitaxel in node-positive breast cancer

  Authors:C. Roy, K. Choudhury, M. Pal, A. Saha, S. Bag, and C. BanerjeeFrom:Indian Journal of Cancer (Vol. 49, Issue 3) Peer-Reviewed

  July-September 20123,461 words Clinical report 1580LByline: C. Roy, K. Choudhury, M. Pal, A. Saha, S. Bag, C. Banerjee Context: Antracycline-Cyclophosphamide (AC) along with Paclitaxel/Docetaxel, either in combination or sequential regimens, is showing superior...

• Colistin: an update on the antibiotic of the 21st century

  Authors:Silpak Biswas, Jean-Michel Brunel, Jean-Christophe Dubus, Martine Reynaud-Gaubert, and Jean-Marc RolainFrom:Expert Review of Anti-infective Therapy (Vol. 10, Issue 8) Peer-Reviewed

  Aug. 201213,837 words Report 1400LAuthor(s): Silpak Biswas 1 , Jean-Michel Brunel 1 , Jean-Christophe Dubus 1 , Martine Reynaud-Gaubert 1 , Jean-Marc Rolain [*] 2 Keywords : acquired resistance; colistimethate sodium; colistin sulfate;...

• Spotlight on rotigotine transdermal patch in Parkinson's disease

  Authors:Mark Sanford and Lesley J. ScottFrom:Drugs & Aging (Vol. 28, Issue 12) Peer-Reviewed

  Dec. 20111,639 words Report 2920LRotigotine transdermal patch (Neupro[R]) [referred to here as rotigotine] is a non-ergolinic dopamine agonist that is available in the EU as monotherapy for the treatment of early Parkinson's disease and as combination...

• Pulse therapy - Evidence versus faith and unconditional other acceptance

  Author:Sanjay SinghFrom:Indian Journal of Dermatology, Venereology, and Leprology (Vol. 76, Issue 2) Peer-Reviewed

  March-April 20101,033 words Letter to the editor Byline: Sanjay. Singh Sir, I deeply appreciate the interest shown in our comments[sup] [1] on dexamethasone cyclophosphamide pulse (DCP) therapy for pemphigus.[sup] [2] In this comment it is mentioned that we...

• Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges

  Authors:C. William Wester, Hermann Bussmann, John Koethe, Claire Moffat, Sten Vermund, Max Essex, et al.From:HIV Therapy (Vol. 3, Issue 5)

  Sept. 200919,847 words Report Author(s): C William Wester [[dagger]] 1 2 3 4 , Hermann Bussmann 1 2 , John Koethe 3 , Claire Moffat 1 2 , Sten Vermund 3 4 , Max Essex 1 2 , Richard G Marlink 1 2 KEYWORDS: adherence; cART; combination...

• Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies

  Authors:Daniel C. Christoph and Martin SchulerFrom:Expert Review of Anticancer Therapy (Vol. 11, Issue 7) Peer-Reviewed

  July 201110,177 words Report 1460LAuthor(s): Daniel C Christoph 1 , Martin Schuler [[dagger]] 2 Keywords : antimitotic agents; BI 2536, BI 6727 (volasertib); GSK461364; GW843682X; HMN-214; NMS-P937 (NMS1286937); novel anticancer drugs; ON...

• From the evolution of toxin resistance to virtual clinical trials: the role of mathematical models in oncology

  Author:Zvia AgurFrom:Future Oncology (Vol. 6, Issue 6) Peer-Reviewed

  June 20105,526 words Report 1460LAuthor(s): Zvia Agur 1 2 Keywords * angiogenesis; bevacizumab; breast cancer; docetaxel; drug development; immunotherapy; neutropenia; treatment personalization; virtual patient; virtual R&D Why has there...

• Will integrin inhibitors have proangiogenic effects in the clinic?

  Authors:Michael Weller, David Reardon, Burt Nabors, and Roger StuppFrom:Nature Medicine (Vol. 15, Issue 7) Peer-Reviewed

  July 20092,131 words Article To the Editor: In a comprehensive analysis, Reynolds et al. (1) recently reported that RGD-mimetic agents such as cilengitide may, under certain experimental conditions, promote rather than inhibit angiogenesis. They...

• Reverse-phase protein microarrays: application to biomarker discovery and translational medicine

  Authors:Amy VanMeter, Michele Signore, Mariaelena Pierobon, Virginia Espina, Lance A Liotta, and Emanuel F Petricoin IIIFrom:Expert Review of Molecular Diagnostics (Vol. 7, Issue 5) Peer-Reviewed

  Sept. 20076,131 words Article Author(s): Amy VanMeter 1 , Michele Signore 2 , Mariaelena Pierobon 3 , Virginia Espina 4 , Lance A Liotta 5 , Emanuel F Petricoin III [[dagger]] 6 Keywords: biomarker; individualized therapy; microarray;...

• Study to evaluate dual AMD therapy

  From:Ophthalmology Times (Vol. 32, Issue 1) Peer-Reviewed

  Jan. 1, 2007211 words Brief article, Clini... 1530LCleveland -- The Cleveland Clinic's Cole Eye Institute will lead a large, multicenter clinical trial to explore combination therapy for wet age-related macular degeneration (AMD). The 2-year, randomized,...

• Atovaquone/proguanil for the prophylaxis and treatment of malaria

  Authors:Samir N Patel and Kevin C KainFrom:Expert Review of Anti-infective Therapy (Vol. 3, Issue 6) Peer-Reviewed

  Dec. 20059,815 words Report Author(s): Samir N Patel 1 , Kevin C Kain 2 [[dagger]] Keywords: atovaquone; cytochrome b; drug resistance; malaria; pharmacokinetics; Plasmodium falciparum; Plasmodium vivax; proguanil; prophylaxis Imported...

• Invasive aspergillosis of the brain: Improvement with lyposomal amphoterecin B and itraconazole

  Authors:Sunil Pradhan and Ramakant YadavFrom:Neurology India (Vol. 55, Issue 3) Peer-Reviewed

  July-September 2007617 words Clinical report 1500LByline: Sunil. Pradhan, Ramakant. Yadav Sir, Intracranial aspergillosis is often an extension from paranasal sinuses and is usually resistant to medical or surgical therapy.[sup] [1],[2] We report a case that...

• Combination pharmacotherapy for neuropathic pain: current evidence and future directions

  Authors:Ian Gilron and Mitchell B MaxFrom:Expert Review of Neurotherapeutics (Vol. 5, Issue 6) Peer-Reviewed

  Nov. 20055,155 words Report Author(s): Ian Gilron 1 [dagger] , Mitchell B Max 2 Keywords: analgesic clinical trials; diabetic neuropathy; drug combinations; neuropathic pain; polypharmacy; postherpetic neuralgia; synergy Neuropathic pain...

• Current and emerging somatic treatment strategies in psychotic major depression

  Authors:Pinhas N Dannon, Katherine Lowengrub, Yehudit Gonopolski, and Moshe KotlerFrom:Expert Review of Neurotherapeutics (Vol. 6, Issue 1) Peer-Reviewed

  Jan. 20065,775 words Report Author(s): Pinhas N Dannon [[dagger]] 1 , Katherine Lowengrub 2 , Yehudit Gonopolski 3 , Moshe Kotler end4 Keywords: electroconvulsive therapy; deep- brain stimulation; major depressive disorder; mood stabilizers;...

• Triple-combination drug therapy prevents COPD acute exacerbations

  Author:Bruce JancinFrom:Family Practice News (Vol. 36, Issue 6)

  Mar. 15, 2006489 words Article 1900LKeystone, Colo. -- Prevention of acute exacerbations has emerged as a major goal in chronic obstructive pulmonary disease--and the way to get there is with combination therapy, Dr. Barry Make said at a meeting sponsored...